Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he has made an assessment of the potential merits of protecting funding for global health multilaterals, in the context of changes to levels of Official Development Assistance funding.

The UK is one of the largest donors to global health multilaterals delivering significant impact. Our £1.65bn funding to Gavi, the Vaccine Allice (2021-2025) is supporting the vaccination of 300 million children and our £1bn funding to the Global Fund for Aids, Tuberculosis and Malaria (2023 - 2025) is expected to save 1.276 million lives and avert 28.25 million new infections. UK support to the World Health Organization, will enable WHO to prioritise activities that will help save over 40 million lives, improve the health of over 6 billion people, and protect an additional 7 billion people from health emergencies. This investment, alongside other international partners' support, will enable the WHO to prioritise activities that will help save over 40 million lives, improve the health of over 6 billion people, and protect an additional 7 billion people from health emergencies. Following the decision to reduce UK Official Development Assistance (ODA) from 0.5 per cent of GNI to 0.3 per cent by 2027 we are taking a rigorous approach to ensure all ODA delivers value for money. Announcements on individual investments will be made following the completion of the Spending Review process.